Zhongzheng Lu

Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species

Yanli Jin, Zhongzheng Lu, Ke Ding et al. · Cancer Research · 2010 · 332 citations · Full text

Chemoprevention Strategy, Apoptosis, Immunology +19

Triptolide Inhibits Bcr-Abl Transcription and Induces Apoptosis in STI571-resistant Chronic Myelogenous Leukemia Cells Harboring T315I Mutation

Xianping Shi, Yanli Jin, Chao Cheng et al. · Clinical Cancer Research · 2009 · 122 citations · Full text

Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-κB signaling and depleting Bcr-Abl

Zhongzheng Lu, Yanli Jin, Chun Chen et al. · Molecular Cancer · 2010 · 108 citations · Full text

Celastrol, a novel HSP90 inhibitor, depletes Bcr–Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation

Zhongzheng Lu, Yanli Jin, Lin Qiu et al. · Cancer Letters · 2009 · 106 citations

Hematological Malignancy, T315i Mutation, Medicine +9

The Antitumor Activity of Homoharringtonine against Human Mast Cells Harboring the KIT D816V Mutation

Yanli Jin, Zhongzheng Lu, Kaiyuan Cao et al. · Molecular Cancer Therapeutics · 2010 · 52 citations

Radiation Oncology, Imatinib-resistant D814y Kit, Signal Transduction +14